Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07563166Completed

Clinicopathologic Features and Staging Risk Factors of Early-Onset Colorectal Cancer

Role: lead

NCT07374822Completed

Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants

Role: lead

NCT07351890Completed

Diagnostic Accuracy of EUS for Colorectal Submucosal Masses

Role: lead

All 3 trials loaded